PubRank

P G Gobbi

Author PubWeight™ 25.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 1993 2.20
2 Interaction between infrared radiation and vitreous substitutes. Arch Ophthalmol 1997 1.42
3 Changing clinical presentation of multiple myeloma. Eur J Cancer 1991 1.24
4 Natural history of idiopathic refractory sideroblastic anemia. Blood 1988 1.17
5 Serum albumin in Hodgkin's disease. Cancer 1985 1.17
6 Severe pruritus should be a B-symptom in Hodgkin's disease. Cancer 1983 0.95
7 A prognostic index for multiple myeloma. Br J Cancer 1996 0.90
8 Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL). Haematologica 1999 0.84
9 New clinical criteria for the assessment of liver involvement in Hodgkin's disease. Eur J Cancer Clin Oncol 1982 0.84
10 ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial. Ann Oncol 2002 0.83
11 Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Haematologica 1998 0.83
12 Photorefractive keratectomy for hyperopia using an erodible disc and axicon lens: 2-year results. J Refract Surg 1998 0.82
13 Peptichemio induction therapy in myelomatosis. Cancer Chemother Pharmacol 1982 0.80
14 Hodgkin's disease and pregnancy. Haematologica 1984 0.80
15 Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes. Haematologica 1992 0.79
16 Prognostic factors in non-Hodgkin's lymphomas. Acta Haematol 1985 0.79
17 Diagnostic approach to lymph node enlargement. Haematologica 1999 0.79
18 Photorefractive keratectomy for hyperopia: long-term nonlinear and vector analysis of refractive outcome. Ophthalmology 1999 0.79
19 Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. A report from the Italian Lymphoma Study Group (GISL). Am J Clin Oncol 1995 0.78
20 Evaluation of three different approaches to perform excimer laser photorefractive keratectomy for myopia. Ophthalmic Surg Lasers 1996 0.78
21 ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL). Leuk Lymphoma 1995 0.78
22 Proliferative activity, response to therapy and survival in multiple myeloma. Haematologica 1984 0.77
23 Diode and Nd:YAG laser contact transscleral cyclophotocoagulation in a human eye: a comparative histopathologic study of the lesions produced using a new fiber optic probe. Ophthalmic Surg 1995 0.77
24 Hyperopia correction using an erodible mask excimer laser delivery system coupled to an axicon: preliminary results. Eur J Ophthalmol 1998 0.77
25 Compound myopic astigmatism correction using a mask in-the-rail excimer laser delivery system. Preliminary results. Eur J Ophthalmol 1997 0.76
26 Acute phase proteins and prognosis in multiple myeloma. Br J Haematol 1993 0.76
27 New semiconductor laser for vitreoretinal surgery. Lasers Surg Med 1996 0.76
28 Reevaluation of prognostic significance of symptoms in Hodgkin's disease. Cancer 1985 0.76
29 Prognostic factors in malignant lymphomas (Hodgkin and non-Hodgkin). Acta Haematol 1987 0.75
30 Photorefractive keratectomy for compound myopic astigmatism with an eye cup erodible mask delivery system. J Refract Surg 1996 0.75
31 Treatment of adult non-Hodgkin's lymphomas. Haematologica 1986 0.75
32 Multivariate analysis of Hodgkin's disease prognosis. Fitness and use of a directly predictive equation. Haematologica 1989 0.75
33 Prognostic significance of serum albumin in Hodgkin's disease. Haematologica 1986 0.75
34 The Merlini, Waldenström, Jayakar staging system revisited. Eur J Haematol Suppl 1989 0.75
35 Reed-Sternberg cell leukaemia. Tumori 1981 0.75
36 Relationship between prognostic factors and therapy in high-grade non-Hodgkin's lymphomas over two decades. Haematologica 1990 0.75
37 Tonsillectomy: a prognostic factor in Hodgkin's disease? Tumori 1981 0.75
38 Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective. Eur J Haematol Suppl 1990 0.75
39 Designing clinical trials on gastric lymphomas and reporting outcomes. Haematologica 2001 0.75
40 Possibility of statistical assessment of splenic involvement in Hodgkin's disease independently of splenectomy. Haematologica 1980 0.75
41 Blood glucose levels in Hodgkin's disease. J Clin Oncol 1985 0.75
42 [Double successive pulmonary and cardiac thromboembolic manifestations in a case of undifferentiated carcinoma of the adrenal glands]. Recenti Prog Med 1984 0.75
43 ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial. Leukemia 1991 0.75
44 Familial myeloma. A new observation in two distinct pairs of siblings. Haematologica 1986 0.75
45 Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas. Do speculative aspects prevail over clinical ones? Eur J Cancer Clin Oncol 1989 0.75
46 Automatic centering of the microscope image for vitreoretinal surgery. Retina 1996 0.75
47 Basic and acidic isoferritins in the serum of patients with Hodgkin's disease. Eur J Cancer Clin Oncol 1983 0.75
48 Intraocular measurements of pressure transients induced by excimer laser ablation of the cornea. Lasers Surg Med 1997 0.75
49 [ProMACE-MOPP vs. ProMACE-CytaBOM polychemotherapies in the treatment of large-cell and unclassifiable non-Hodgkin's lymphomas]. Ann Ital Med Int 1992 0.75
50 [Spontaneous remission of visceral metastases of hypernephroma after nephrectomy. Description of a case and review of pathogenetic hypotheses]. Recenti Prog Med 1991 0.75
51 Design and characterization of a diode-pumped, single longitudinal and transverse mode, intracavity-doubled cw Nd:YAG laser. Appl Opt 1997 0.75
52 Case report of primary bone lymphoma with disseminated presentation. Haematologica 1985 0.75
53 Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. Haematologica 1987 0.75
54 [Idiopathic myelodysplastic syndromes. A caseload contribution]. Ann Ital Med Int 1986 0.75
55 High-Repetition-Rate Q-Switched Diode-Pumped Nd:YAG Laser at 1.444 mum. Appl Opt 1998 0.75
56 Chronic granulocytic leukemia. A retrospective study of 91 cases. I. Hemogram at diagnosis and research of prognostic factors. Haematologica 1979 0.75
57 Serum IgD in Hodgkin's disease. Haematologica 1981 0.75
58 A motorized hand piece for injectable lenses. Ophthalmic Surg Lasers 1997 0.75
59 Morphological and cytochemical studies of circulating Hodgkin's and Reed-Sternberg cells. Basic Appl Histochem 1980 0.75
60 Progressive necrotic myelopathy as a paraneoplastic syndrome: report of a case and some pathogenetic considerations. J Intern Med 1992 0.75
61 Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial. Haematologica 1994 0.75
62 The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients. Haematologica 1988 0.75
63 Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators. Haematologica 1979 0.75
64 [A case of scleroderma with sclerodermic renal crisis and association with the Vogt-Koyanagi-Harada syndrome]. Presse Med 1985 0.75
65 Plasma zinc levels in Hodgkin's disease. Evaluation of 37 cases. Haematologica 1978 0.75
66 Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators. Acta Haematol 1982 0.75